Found: 30
Select item for more details and to access through your institution.
Risk of unplanned visits for colorectal cancer outpatients receiving chemotherapy: a case-crossover study.
- Published in:
- Supportive Care in Cancer, 2014, v. 22, n. 9, p. 2527, doi. 10.1007/s00520-014-2234-z
- By:
- Publication type:
- Article
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep06828
- By:
- Publication type:
- Article
Physical and functional association of CD45 and CD3-TCR complex on CD1<sup>+</sup> human thymocytes. Evidence that the engagement of CD45 molecules can prevent CD1<sup>+</sup> thymocytes from apoptosis.
- Published in:
- International Immunology, 1996, v. 8, n. 12, p. 1947, doi. 10.1093/intimm/8.12.1947
- By:
- Publication type:
- Article
HLA-G 3'UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 7, p. 1366, doi. 10.3390/ijms18071366
- By:
- Publication type:
- Article
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
- Published in:
- British Journal of Cancer, 2022, v. 127, n. 5, p. 957, doi. 10.1038/s41416-022-01852-0
- By:
- Publication type:
- Article
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
- Published in:
- 2022
- By:
- Publication type:
- journal article
The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2019, v. 10, n. 2, p. 368, doi. 10.1002/jcsm.12368
- By:
- Publication type:
- Article
Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 10, p. 2029, doi. 10.1007/s00432-018-2709-2
- By:
- Publication type:
- Article
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte‐to‐Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 8, p. 661, doi. 10.1634/theoncologist.2019-0780
- By:
- Publication type:
- Article
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47627-1
- By:
- Publication type:
- Article
Khorana score and thromboembolic risk in stage II-III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835919899850
- By:
- Publication type:
- Article
Neurosurgical management and postoperative whole-brain radiotherapy for colorectal cancer patients with symptomatic brain metastases.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2009, v. 135, n. 3, p. 451, doi. 10.1007/s00432-008-0468-1
- By:
- Publication type:
- Article
Expression of human NKRP1A by CD34.
- Published in:
- European Journal of Immunology, 1996, v. 26, n. 6, p. 1266, doi. 10.1002/eji.1830260613
- By:
- Publication type:
- Article
Dissection of lymphocyte function-associated antigen 1-dependent adhesion and signal transduction in human natural killer cells shown by the use of cholera or pertussis toxin.
- Published in:
- European Journal of Immunology, 1996, v. 26, n. 5, p. 967, doi. 10.1002/eji.1830260502
- By:
- Publication type:
- Article
p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans.
- Published in:
- European Journal of Immunology, 1995, v. 25, n. 2, p. 369, doi. 10.1002/eji.1830250210
- By:
- Publication type:
- Article
Expression of a wide T cell receptor Vβ repertoire in human T lymphocytes derived in vitro from embryonic liver cell precursors.
- Published in:
- European Journal of Immunology, 1994, v. 24, n. 9, p. 2258, doi. 10.1002/eji.1830240949
- By:
- Publication type:
- Article
CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules.
- Published in:
- European Journal of Immunology, 1993, v. 23, n. 10, p. 2454, doi. 10.1002/eji.1830231012
- By:
- Publication type:
- Article
A novel pathway of human B cell activation initiated by CK226 surface antigen.
- Published in:
- European Journal of Immunology, 1990, v. 20, n. 5, p. 1161, doi. 10.1002/eji.1830200532
- By:
- Publication type:
- Article
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5451, doi. 10.3390/cancers15225451
- By:
- Publication type:
- Article
The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 175, doi. 10.3390/cancers15010175
- By:
- Publication type:
- Article
Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3504, doi. 10.3390/cancers13143504
- By:
- Publication type:
- Article
From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1330, doi. 10.3390/cancers12051330
- By:
- Publication type:
- Article
Prognostic evaluation in palliative care: final results from a prospective cohort study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy.
- Published in:
- Frontiers in Pharmacology, 2018, p. N.PAG, doi. 10.3389/fphar.2018.01101
- By:
- Publication type:
- Article
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines.
- Published in:
- International Journal of Cancer, 2015, v. 137, n. 12, p. 2971, doi. 10.1002/ijc.29654
- By:
- Publication type:
- Article
HLA-G 3’UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0144000
- By:
- Publication type:
- Article
CK7 and consensus molecular subtypes as major prognosticators in <sup>V600E</sup>BRAF mutated metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article